-
1481“…We present the case of a patient who first developed symptoms of celiac disease while on interferon-based therapy for treatment of chronic hepatitis C. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1482por Kim, Miyoung, Hwang, Seungwoo, Park, Kiejung, Kim, Seon Young, Lee, Young Kyung, Lee, Dong Soon“…RCMD and RAEB simultaneously showed an up-regulation of interferon alpha/beta signaling and the ISG15 antiviral mechanism, and a significant fraction of the RAEB vs. control DEGs were also putative targets of transcription factors IRF and ICSBP. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1483por Majumdar, Tanmay, Chattopadhyay, Saurabh, Ozhegov, Evgeny, Dhar, Jayeeta, Goswami, Ramansu, Sen, Ganes C., Barik, Sailen“…Such genes include type I interferons (IFNs) as well as Interferon Stimulated Genes (ISGs). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1484por Yeh, Ming-Lun, Peng, Cheng-Yuan, Dai, Chia-Yen, Lai, Hsueh-Chou, Huang, Chung-Feng, Hsieh, Ming-Yen, Huang, Jee-Fu, Chen, Shinn-Cherng, Lin, Zu-Yau, Yu, Ming-Lung, Chuang, Wan-Long“…BACKGROUND: Studies are limited on pegylated interferon (Peg-IFN) therapy for chronic hepatitis B (CHB) patients who failed or relapsed on previous antiviral therapy. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1485por Shirani, Afsaneh, Zhao, Yinshan, Petkau, John, Gustafson, Paul, Karim, Mohammad Ehsanul, Evans, Charity, Kingwell, Elaine, van der Kop, Mia L., Oger, Joel, Tremlett, Helen“…We examined (1) patient characteristics and disease-modifying drug (DMD) exposure in late-onset (LOMS, ≥50 years at symptom onset) versus adult-onset (AOMS, 18–<50 years) MS and (2) the association between interferon-beta (IFNβ) and disability progression in older relapsing-onset MS adults (≥50 years). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1486por Hsu, Ching-Sheng, Chao, You-Chen, Lin, Hans Hsienhong, Chen, Ding-Shinn, Kao, Jia-Horng“…We identified 6 trials evaluated the effectiveness of interferon (IFN)-alfa treatment, 3 studies examined pegylated interferon-alfa treatment, and 2 studies examined IFN-beta treatment. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1487“…Type I interferon (IFN) is one of the first lines of cellular defense against viral pathogens. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1488por Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa, Bagdonatė, Loreta, Griskevicius, Laimonas, Valceckiene, Vilma, Stoskus, Mindaugas“…BACKGROUND: Neutralizing antibodies (NAb) to interferon-beta (IFN-β) are associated with reduced bioactivity and efficacy of IFN-β in multiple sclerosis (MS). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1489por Génin, Pierre, Cuvelier, Frédérique, Lambin, Sandrine, Côrte-Real Filipe, Josina, Autrusseau, Elodie, Laurent, Christine, Laplantine, Emmanuel, Weil, RobertEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1490por Kimura, Tominori, Jiang, Shiwen, Yoshida, Noriyuki, Sakamoto, Ryou, Nishizawa, Mikio“…We previously reported natural antisense RNA (AS) as an important modulator of interferon-α1 (IFN-α1) mRNA levels by promoting IFN-α1 mRNA stability. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1491por Pérez-Miralles, Francisco Carlos, Sastre-Garriga, Jaume, Vidal-Jordana, Angela, Río, Jordi, Auger, Cristina, Pareto, Deborah, Tintoré, Mar, Rovira, Alex, Montalban, Xavier“…OBJECTIVE: To investigate the association between brain volume loss during the first year of interferon treatment and clinical outcome at 4 years. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1492por Li, Tao, Bao, Lei, Diao, Ni, Sun, Feng, Gao, Yan, Wong, Ka-Wing, Xi, Xiuhong, Liu, Xuhui, Wang, Sen, Wu, Jing, Hui, Ma, Fan, Xiaoyong, Zhang, Ying, Zhang, Wenhong, Lu, Shuihua“…This study aimed at evaluating the ability of interferon-gamma release assays (IGRAs) in the detection of active TB in human immunodeficiency virus-negative children vaccinated with Bacille Calmette–Guérin and investigating the effect of prednisolone treatment on the IGRAs performance. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1493por Yoon, Seung-Kew, Kim, Sung Soo, Park, Young Min, Shim, Kyu Sik, Lee, Chang Don, Sun, Hee Sik, Park, Doo Ho, Kim, Boo Sung, Ryu, Wang Shick, Cho, Joong Myung“…OBJECTIVES: Interferon is the only established teatment for chronic hepatitis C but the host-dependent or virus-related factors affecting the response rate to interferon therapy are not yet dear. …”
Publicado 1995
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1494por Chen, Junjie, Zhao, Jialu, Chen, Lefu, Dong, Nian, Ying, Zhaojian, Cai, Zhenzhen, Ji, Dongxiang, Zhang, Yong, Dong, Li, Li, Yuping, Jiang, Lei, Holtzman, Michael J., Chen, Chengshui“…BACKGROUND: Interferons (IFNs) have potent anti-proliferative, pro-apoptotic, and immunomodulatory activities against cancer. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1495por Wrensch, Florian, Karsten, Christina B., Gnirß, Kerstin, Hoffmann, Markus, Lu, Kai, Takada, Ayato, Winkler, Michael, Simmons, Graham, Pöhlmann, Stefan“…Ebolaviruses are highly pathogenic in humans and nonhuman primates and pose a severe threat to public health. The interferon-induced transmembrane (IFITM) proteins can restrict entry of ebolaviruses, influenza A viruses, and other enveloped viruses. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1496por Arellano, Gabriel, Ottum, Payton A., Reyes, Lilian I., Burgos, Paula I., Naves, Rodrigo“…The role of interferon (IFN)-γ in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), has remained as an enigmatic paradox for more than 30 years. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1497por Wolpert, Fabian, Happold, Caroline, Reifenberger, Guido, Florea, Ana-Maria, Deenen, René, Roth, Patrick, Neidert, Marian Christoph, Lamszus, Katrin, Westphal, Manfred, Weller, Michael, Eisele, GünterEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1498por Ottum, Payton A., Arellano, Gabriel, Reyes, Lilian I., Iruretagoyena, Mirentxu, Naves, Rodrigo“…Most studies on the role of interferon (IFN)-γ in the pathogenesis and progression of EAE have focused on peripheral immune cells, while its action on central nervous system (CNS)-resident cells has been less explored. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1499por Shimojima, Masayuki, Fukushi, Shuetsu, Tani, Hideki, Taniguchi, Satoshi, Fukuma, Aiko, Saijo, Masayuki“…METHODS: Vero cells were pre-treated with interferons (IFNs) α, β, and γ alone and in combination with ribavirin drugs and inoculated with SFTS virus. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1500“…Objective. Interferon therapy of HCV infected patients is associated with development of thyroid dysfunctions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto